A Review Of sodium pentobarbital nembutal
A Review Of sodium pentobarbital nembutal
Blog Article
pentobarbital will decrease the level or effect of lefamulin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Keep away from or Use Alternate Drug. Stay clear of coadministration of lefamulin with potent or average CYP3A inducers unless the benefit outweighs threats. Observe for minimized efficacy.
pentobarbital will decrease the extent or effect of quinine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unfamiliar.
Contraindicated (one)pentobarbital will decrease the extent or effect of lonafarnib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Lonafarnib is often a delicate CYP3A4 substrate. Coadministration with solid or reasonable CYP3A4 inducers is contraindicated.
pentobarbital will minimize the extent or effect of ombitasvir/paritaprevir/ritonavir & dasabuvir (DSC) by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Strong CYP3A4 inducers may lessen partiaprevir and ritonavir concentrations, and as a consequence lessened efficacy of Viekira Pak
pentobarbital will decrease the extent or effect of siponimod by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Stay away from or Use Alternate Drug. Coadministration of siponimod with a drug that causes average CYP2C9 plus a moderate or sturdy CYP3A4 inducer just isn't advised.
pentobarbital will lower the level or effect of estradiol by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.
pentobarbital will minimize the level or effect of conjugated estrogens, vaginal by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.
pentobarbital decreases levels of elvitegravir/cobicistat/emtricitabine/tenofovir DF by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. May produce lack of virologic reaction and possible resistance.
Doxycycline: Phenobarbital has been revealed to shorten the half-life of doxycycline for as long as two weeks immediately after barbiturate therapy is discontinued.
pentobarbital will minimize the extent or effect of tamoxifen by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of.
pentobarbital will lessen the level check here or effect of lonafarnib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Lonafarnib is often a sensitive CYP3A4 substrate. Coadministration with strong or moderate CYP3A4 inducers is contraindicated.
Monitor Closely (1)pentobarbital will minimize the level or effect of osilodrostat by affecting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will lower the level or effect of vinblastine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Significance Mysterious.
pentobarbital will lower the extent or effect of carbamazepine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.